Robert T Booth

US Patent:

20070078314, Apr 5, 2007

Filed:

Sep 29, 2006

Appl. No.:

11/529224

Inventors:

Richard Grounsell - Greenville SC, US
Robert Booth - Columbus NC, US

International Classification:

A61B 5/00

US Classification:

600319000

Abstract:

The method and system for managing a patient's blood glucose level predicts an insulin dosing rate to bring a patient's blood glucose level into a preferred target range within a predetermined time interval. The system includes a processor which actuates a blood glucose computer program to measure and predict the patient's blood glucose level. An input mechanism allows for insertion of a preferred target range of the patient's blood glucose level and further permits input of various patient data parameters. The processor calculates the optimum insulin dosing rate for the patient based upon the type of insulin dosing whether it be intravenous dosing and/or subcutaneous dosing. A display mechanism displays the patient dosing parameters and an alarm mechanism alerts a user when the patient's blood glucose level is outside of the preferred patient blood glucose target range.

US Patent:

20070168136, Jul 19, 2007

Filed:

Jan 19, 2007

Appl. No.:

11/625131

Inventors:

ROBERT C. BOOTH - COLUMBUS NC, US
RICHARD L. GROUNSELL - GREENVILLE SC, US
MAURICE E. DURSCHLAG - CHARLOTTE NC, US

International Classification:

G06F 19/00
A61B 5/00

US Classification:

702 19, 600300

Abstract:

A system is provided for a keto-acidosis protocol which includes a computer processor having patient parameter data input. The patient parameter data input to the computer processor may include the patient's blood glucose level, a target patient blood glucose level, a patient's carbon dioxide level, a patient's sodium level, a patient's blood pH value, and the patient's potassium level which has been measured. A patient hydration computer program assesses the patient's hydration state. Coupled to the patient hydration computer program is a patient potassium computer program to assess the patient's potassium level and a patient blood pH value computer program assesses the patient's blood pH value. A display monitor is coupled to the computer processor for displaying indicia thereon responsive to the actuation of the patient hydration computer program, the patient potassium computer program, and the patient blood pH value computer program.

US Patent:

20180128765, May 10, 2018

Filed:

Jan 5, 2018

Appl. No.:

15/862819

Inventors:

- Greenville SC, US
Robert C. Booth - Columbus NC, US

Assignee:

Aseko, Inc. - Greenville SC

International Classification:

G01N 27/327

Abstract:

A method and system for optimizing insulin dosages for diabetic subjects which includes a processor for calculating basal and bolus dosages to be recommended for meal types including breakfast, lunch, dinner, snack, or at miscellaneous times. The bolus calculations are specifically directed to time periods which are taken from either pre-meal, post-meal, bedtime, mid-sleep or miscellaneous times. The processor calculates an optimized bolus for a specific time period and meal type based upon prior basal dosages, prior blood glucose doses, hypoglycemia thresholds, mid-point of target ranges, and subject insulin sensitivity factors. A display is provided to the subject for sensing the optimized insulin dosage recommended at a specific time period and for a specific meal type.